To Study The Effectiveness Of Low Molecular Weight Heparin In Treatment Of Acute Pancreatitis
Phase 2
- Conditions
- Health Condition 1: E349- Endocrine disorder, unspecified
- Registration Number
- CTRI/2021/02/031345
- Lead Sponsor
- VCMARUDURAJ
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients Who Are Diagnosed With Acute Pancreatitis.
Age Group â?? Above 18 Years , Gender â?? Male And Female.
Patients Who Are Willing To Participitate In The Study.
Exclusion Criteria
Patients Who Are Not Willing To Participitate In Study
Necrotising Pancreatitis
Pregnant
Breastfeeding
Coagulation Disorder
Undergoing Haemodialysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study The Effectiveness Of Low Molecular Weight Heparin In Treatment Of Acute Pancreatitis <br/ ><br>Timepoint: 18 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method To Study The Treatment Outcome Of Low Molecular Weight Heparin In Acute Pancreatitis <br/ ><br>Timepoint: 18 months